Manuela Zaccolo

Prof. Dr. Manuela Zaccolo

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2002 in Science
Verified
Journal Article
Closed access
PDF file
MZManuela Zaccolo
Manuela Zaccolo
TPTullio Pozzan
Tullio Pozzan
The second messenger cyclic adenosine monophosphate (cAMP) is the most important modulator of sympathetic control over cardiac contractility. In cardiac myocytes and many other cell types, however, cAMP transduces the signal generated upon stimulation of various receptors and activates different cellular functions, raising the issue of how specificity can be achieved. In the general field of signal transduction, the view is emerging that specificity is guaranteed by tight localization of signaling events. Here, we show that in neonatal rat cardiac myocytes, β-adrenergic stimulation generates multiple microdomains with increased concentration of cAMP in correspondence with the region of the transverse tubule/junctional sarcoplasmic reticulum membrane. The restricted pools of cAMP show a range of action as small as approximately 1 micrometer, and free diffusion of the second messenger is limited by the activity of phosphodiesterases. Furthermore, we demonstrate that such gradients of cAMP specifically activate a subset of protein kinase A molecules anchored in proximity to the T tubule.

1 December 1999 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
MZManuela Zaccolo
Manuela Zaccolo
FGFrancesca De Giorgi
Francesca De Giorgi
CCCharles Y. Cho
Charles Y. Cho
LFLuxin Feng
Luxin Feng
TKTom Knapp
Tom Knapp
TPTullio Pozzan
Tullio Pozzan

1 December 2004 in EMBO Reports
Verified
Journal Article
Open access
PDF file
BPBas Ponsioen
Bas Ponsioen
JZJun Zhao
Jun Zhao
JRJurgen Riedl
Jurgen Riedl
FZFried Zwartkruis
Fried Zwartkruis
GKGerard van der Krogt
Gerard van der Krogt
KJKees Jalink
Kees Jalink
Epac1 is a guanine nucleotide exchange factor for Rap1 that is activated by direct binding of cAMP. In vitro studies suggest that cAMP relieves the interaction between the regulatory and catalytic domains of Epac. Here, we monitor Epac1 activation in vivo by using a CFP–Epac–YFP fusion construct. When expressed in mammalian cells, CFP–Epac–YFP shows significant fluorescence resonance energy transfer (FRET). FRET rapidly decreases in response to the cAMP‐raising agents, whereas it fully recovers after addition of cAMP‐lowering agonists. Thus, by undergoing a cAMP‐induced conformational change, CFP–Epac–YFP serves as a highly sensitive cAMP indicator in vivo . When compared with a protein kinase A (PKA)‐based sensor, Epac‐based cAMP probes show an extended dynamic range and a better signal‐to‐noise ratio; furthermore, as a single polypeptide, CFP–Epac–YFP does not suffer from the technical problems encountered with multisubunit PKA‐based sensors. These properties make Epac‐based FRET probes the preferred indicators for monitoring cAMP levels in vivo .

9 July 2004 in Circulation Research
Verified
Journal Article
Closed access
PDF file
MMMarco Mongillo
Marco Mongillo
TMTheresa McSorley
Theresa McSorley
SESandrine Evellin
Sandrine Evellin
ASArvind Sood
Arvind Sood
VLValentina Lissandron
Valentina Lissandron
MZManuela Zaccolo
Manuela Zaccolo
Cardiac myocytes have provided a key paradigm for the concept of the compartmentalized cAMP generation sensed by AKAP-anchored PKA. Phosphodiesterases (PDEs) provide the sole route for degrading cAMP in cells and are thus poised to regulate intracellular cAMP gradients. PDE3 and PDE4 represent the major cAMP degrading activities in rat ventriculocytes. By performing real-time imaging of cAMP in situ, we establish the hierarchy of these PDEs in controlling cAMP levels in basal conditions and on stimulation with a β-adrenergic receptor agonist. PDE4, rather than PDE3, appears to be responsible for modulating the amplitude and duration of the cAMP response to beta-agonists. PDE3 and PDE4 localize to distinct compartments and this may underpin their different functional roles. Our findings indicate the importance of distinctly localized PDE isoenzymes in determining compartmentalized cAMP signaling.

8 June 2007 in Circulation Research
Verified
Journal Article
Closed access
PDF file
MZManuela Zaccolo
Manuela Zaccolo
MMMatthew A. Movsesian
Matthew A. Movsesian
Cyclic nucleotide phosphodiesterases regulate cAMP-mediated signaling by controlling intracellular cAMP content. The cAMP-hydrolyzing activity of several families of cyclic nucleotide phosphodiesterases found in human heart is regulated by cGMP. In the case of PDE2, this regulation primarily involves the allosteric stimulation of cAMP hydrolysis by cGMP. For PDE3, cGMP acts as a competitive inhibitor of cAMP hydrolysis. Several cGMP-mediated responses in cardiac cells, including a potentiation of Ca2+currents and a diminution of the responsiveness to β-adrenergic receptor agonists, have been shown to result from the effects of cGMP on cAMP hydrolysis. These effects appear to be dependent on the specific spatial distribution of the cGMP-generating and cAMP-hydrolyzing proteins, as well as on the intracellular concentrations of the two cyclic nucleotides. Gaining a more precise understanding of how these cross-talk mechanisms are individually regulated and coordinated is an important direction for future research.

1 February 1996 in Journal of Molecular Biology
Verified
Journal Article
Closed access
MZManuela Zaccolo
Manuela Zaccolo
DWDavid Williams
David Williams
DBDaniel M. Brown
Daniel M. Brown
EGErmanno Gherardi
Ermanno Gherardi